Hepatocyte Growth Factor in Patients with Three Different Stages of Chronic Liver Disease including Hepatocellular Carcinoma, Cirrhosis and Chronic Hepatitis: An Immunohistochemical Study

Banu Bilezikçi; Asuman Nihan Haberal; Beyhan Demirhan

doi:10.1155/2001/930629

Canadian Journal of Gastroenterology (Jan 2001)

Hepatocyte Growth Factor in Patients with Three Different Stages of Chronic Liver Disease including Hepatocellular Carcinoma, Cirrhosis and Chronic Hepatitis: An Immunohistochemical Study

Banu Bilezikçi,
Asuman Nihan Haberal,
Beyhan Demirhan

Affiliations

Banu Bilezikçi: Baskent University Faculty of Medicine, Department of Pathology, Bahçelievler, Ankara, Turkey
Asuman Nihan Haberal: Baskent University Faculty of Medicine, Department of Pathology, Bahçelievler, Ankara, Turkey
Beyhan Demirhan: Baskent University Faculty of Medicine, Department of Pathology, Bahçelievler, Ankara, Turkey

DOI: https://doi.org/10.1155/2001/930629
Journal volume & issue: Vol. 15, no. 3
pp. 159 – 165

Abstract

Read online

BACKGROUND AND AIMS: The specific role of hepatocyte growth factor in liver disease is unknown. The presence and density of this factor in patients with three different stages of liver disease were investigated, with the aim of assessing its prognostic significance.

Published in Canadian Journal of Gastroenterology

ISSN: 0835-7900 (Print); 1916-7237 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal